Standard Operating Procedure for Product Registration Support for Emerging Markets
| Department | Regulatory Affairs |
| SOP No. | RA/2026/660 |
| Supersedes | NA |
| Page No. | 1 of X |
| Issue Date | 10/04/2026 |
| Effective Date | 10/04/2026 |
| Review Date | 10/04/2028 |
Purpose
This Standard Operating Procedure (SOP) defines the process for providing comprehensive support for product registration activities in emerging markets. It aims to ensure regulatory compliance, timely submission, and documentation accuracy, supporting the control objective of maintaining quality assurance and legal market access in diverse regulatory environments.
Scope
This SOP applies to all regulatory affairs personnel involved in product registration for any pharmaceutical product intended for emerging markets. It covers interactions with regulatory authorities, preparation and submission of dossiers, tracking of application status, and updating internal records. Activities not related to emerging market registrations or post-approval changes are excluded.
Responsibilities
The roles involved include:
- Regulatory Affairs Executives – preparing and compiling registration dossiers.
- Regulatory Affairs Managers – reviewing and approving submissions before dispatch.
- Quality Assurance – verifying compliance with internal policies.
- Documentation Control – maintaining controlled document archives.
- Regulatory Affairs Head – oversight on regulatory strategy and compliance adherence.
Accountability
The Regulatory Affairs Head is accountable for implementation, ensuring compliance with this SOP, conducting periodic reviews for effectiveness, overseeing corrective actions in case of deviations, escalating issues as needed, and ensuring continuous training of relevant personnel.
Procedure
1. Preparation and Prerequisites:
Identify the target emerging market regulatory requirements based on latest guidelines and updates from relevant authorities. Verify product registration dossier templates specific to the market. Ensure access to all product development and quality documentation necessary for dossier compilation.
2. Documentation and Compilation:
Gather all required data including quality, safety, efficacy, and labeling information. Compile documents in the prescribed format ensuring completeness, accuracy, and compliance with the country-specific dossier structure. Apply document version controls and include necessary certifications and declarations.
3. Internal Review and Approval:
Submit the draft dossier for internal review by the Regulatory Affairs Manager and Quality Assurance. Address any observations or corrective actions documented. Obtain formal approval signatures before submission.
4. Submission and Tracking:
Submit the completed dossier to the relevant regulatory authority using the approved submission method (electronic or hard copy). Record submission details and acknowledgment receipts. Monitor application progress through regulatory portals or official communication channels.
5. Communication and Query Management:
Maintain diligent communication with regulatory bodies. Receive and respond promptly to any queries or requests for additional information. Coordinate with relevant stakeholders for rapid resolution of regulatory questions.
6. Documentation and Record Retention:
Ensure all submission documents, correspondence, approvals, and relevant communications are archived as per the internal documentation policy and regulatory requirements. Maintain confidentiality and secure access to records.
7. Deviation and Change Management:
Report any deviations or issues encountered during the registration process following the internal deviation management SOP. Implement corrective and preventive actions as needed.
8. Periodic Review and Continuous Improvement:
Conduct periodic reviews of registration activities and regulatory changes in emerging markets. Update this SOP and training materials accordingly to maintain compliance and improve operational efficiency.
Abbreviations
RA – Regulatory Affairs
SOP – Standard Operating Procedure
Dossier – Complete set of documents for regulatory submission
QA – Quality Assurance
GMP – Good Manufacturing Practices
Documents
- Product Registration Dossier Template (Annexure-1)
- Submission Tracking Log (Annexure-2)
- Regulatory Query Response Form (Annexure-3)
References
ICH Guidelines for Pharmaceuticals, WHO Technical Report Series, Local Emerging Market Regulatory Guidelines, Internal Document Control Policy, GMP Documentation Practices, and Relevant Pharmacopoeial Standards.
Version
1.0
Approval
| Prepared By | |
| Checked By | |
| Approved By |
Annexures
Annexure-1: Product Registration Dossier Template
Purpose: To provide a structured template for compiling product registration dossiers for emerging markets ensuring completeness and regulatory compliance.
| Section | Contents |
|---|---|
| 1. Administrative Information | Application form, Cover letter, Applicant details |
| 2. Quality Documentation | CMC data, Batch analysis, Stability data |
| 3. Safety and Efficacy | Clinical data summary, Pharmacovigilance plan |
| 4. Labeling and Packaging | Proposed labels, Package inserts |
| 5. Certifications | GMP certificates, Free sale certificate |
| 6. Annexes | Additional supporting documents |
Annexure-2: Submission Tracking Log
Purpose: To systematically track submission dates, receipt acknowledgments, status updates, and correspondence regarding product registrations in emerging markets.
| Submission ID | Product Name | Market/Country | Submission Date | Acknowledgment Date | Current Status | Next Action Due |
|---|---|---|---|---|---|---|
| SUB-EM-2026-001 | Product A | Country X | 05/03/2026 | 12/03/2026 | Under Review | Response to Query by 20/04/2026 |
| SUB-EM-2026-002 | Product B | Country Y | 08/03/2026 | 15/03/2026 | Approved | Maintain Registration Annually |
Annexure-3: Regulatory Query Response Form
Purpose: To document and manage responses to regulatory authority queries related to product registration submissions.
| Field | Details |
|---|---|
| Query Reference No. | RQ-2026-015 |
| Date Received | 10/03/2026 |
| Product Name | Product A |
| Query Description | Request for additional stability data under accelerated conditions. |
| Response Prepared By | Regulatory Affairs Executive |
| Response Submission Date | 18/03/2026 |
| Summary of Response | Provided supplemental stability study report with updated protocol and results. |
| Authorized Signature | _____________________________ |
Revision History
| Revision Date | Revision No. | Revision Details | Reason for Revision | Approved By |
| 10/04/2026 | 1.0 | Initial issue | New SOP creation |